The Role of Biomarkers and Companion / Complementary Diagnostics in Immuno-Oncology Trials

Covance Chief Scientific Officer Steven M. Anderson, PhD during our recent webinar where he discussed the spectrum of immunotherapy development considerations and their implications for drug developers. This webinar covers a variety of topics, including: Biomarker approaches, Cell-based assays, Tissue based biomarker assays, Genomic biomarkers,Engaging a CRO or lab partner